Our results showed that the levels of inflammatory factors, IL-1α, IL-2, IL-10 and IFN-γ were augmented in MPGN model rats, as well as in HMCs treated with LPS. This evidence concerns the gene IL10 and primary membranoproliferative glomerulonephritis.